Product Details

Bio-Celecoxib

Celecoxib
100 mg
Capsule


DIN/PIN/NPN

02426382

Manufacturer

Biomed Pharma

Formulary Listing Date

2016-02-25  

Unit Price

0.1279

Amount MOH Pays

0.1279

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

Celecoxib 100 mg Capsule: NSAIDs have a high rate of serious adverse effects in the elderly. When prescribing NSAIDs, the minimal effective dose for the shortest period of time should be used. In nonspecific pain and/or osteoarthritis, in the absence of joint inflammation (swelling), acetaminophen is a better first choice for analgesia. The most effective treatment to prevent NSAID-gastritis is misoprostol; although H-2 antagonists, such as ranitidine or cimetidine, are commonly used, they are not as effective. NSAIDs can significantly aggravate hypertension and congestive heart failure; ASA in doses below 1 gram per day is a better choice than other NSAID options if anti-inflammatory effects are required in patients with these conditions. Low dose ASA has additional benefits for anti-platelet indications that are not provided by other NSAIDs, and should be given in preference or in addition to other NSAIDs for patients with vascular indications.

ATC Code

M01AH01

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02288915 Teva-Celecoxib 0.1279 0.1279
02442639 Sdz Celecoxib 0.1279 0.1279
02412373 Ran-Celecoxib 0.1279 0.1279
02355442 PMS-Celecoxib 0.1279 0.1279
02479737 NRA-Celecoxib 0.1279 0.1279
02412497 Mint-Celecoxib 0.1279 0.1279
02495465 M-Celecoxib 0.1279 0.1279
02420058 Mar-Celecoxib 0.1279 0.1279
02424533 Jamp-Celecoxib 0.1279 0.1279
02436299 Celecoxib 0.1279 0.1279
02429675 Celecoxib 0.1279 0.1279
02239941 Celebrex 0.7988 0.1279
02426382 Bio-Celecoxib 0.1279 0.1279
02445670 Auro-Celecoxib 0.1279 0.1279
02418932 Apo-Celecoxib 0.1279 0.1279
02437570 AG-Celecoxib 0.1279 0.1279
02420155 Act Celecoxib 0.1279 0.1279
02517116 PMSC-Celecoxib 0.1279 0.1279
 

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
316 1 year

Osteoarthritis

For patients who have failed an adequate trial of acetaminophen (e.g. acetaminophen 1g QID for several weeks) and have had:

- History of a documented, clinically significant ulcer or GI bleed; or
- Failure or intolerance to at least three listed NSAIDS.

Note: The maximum daily dose of celecoxib which will be reimbursed for the treatment of osteoarthritis is 200mg.

317 1 year

Rheumatoid arthritis

For patients who have had:

- History of a documented, clinically significant ulcer or GI bleed; or
- Failure or intolerance to at least three listed NSAIDS.

Note: The maximum daily dose of celecoxib which will be reimbursed for the treatment of rheumatoid arthritis is 400mg.

 

EAP Criteria

NO

Product Monograph

View Monograph